Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
The FDA is requiring the drug company to submit more clinical data.
Read More »AstraZeneca’s New Diabetes Drug Gets Delayed
Blood Type May Predict Diabetes Risk After Gestational Diabetes
Blood group also possible indicator of development of gestational diabetes itself.
Read More »Cardiovascular Mortality Not Associated with Insulin Dosage
Patient history of CVD, higher A1C factored into risk.
Read More »Optimism Can Benefit Heart Disease Patients
Positive outlook more likely to inspire positive lifestyle modifications.
Read More »The Influenza Vaccine Antibody Response in T2DM Patients
New research shows similar response in seniors with diabetes as those without.
Read More »Potential Benefit With Sensor-Augmented Insulin Pump Therapy
Findings suggest treatment may reduce urine albumin creatinine ratio in T1DM.
Read More »Improvements Prompt Rise in Insulin Cost
Medicaid reimbursement for insulin skyrocketed within the last decade.
Read More »Management of Diabetes by Prescribing vs. Non-Prescribing Nurses
Findings show longer relationships and longer consultations between prescribing nurses and diabetic patients.
Read More »Less Hospitalizations for Diabetic Patients Under Nurse Practitioners’ Care
Study finds NPs provide comparable quality of clinical care as physicians.
Read More »Fewer Adverse Effects Observed When Adding Dipeptidyl Peptidase-4 Inhibitors to Metformin Therapy
Combination does not alter myocardial infarction, hospitalization risks.
Read More »